about
The emerging role of oxylipins in thrombosis and diabetesShotgun lipidomics in substantiating lipid peroxidation in redox biology: Methods and applicationsLipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenalUnraveling the complex relationship triad between lipids, obesity, and inflammationTargeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids.A randomized controlled trial of green tea catechins in protection against ultraviolet radiation-induced cutaneous inflammationGenome-Wide DNA Methylation in Mixed Ancestry Individuals with Diabetes and Prediabetes from South Africa.Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test.Lipidomics applications in health, disease and nutrition research.Targeted quantification of lipid mediators in skeletal muscles using restricted access media-based trap-and-elute liquid chromatography-mass spectrometry.Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment.Membrane fatty acid heterogeneity of leukocyte classes is altered during in vitro cultivation but can be restored with ad-hoc lipid supplementation.Inflammatory Resolution Triggers a Prolonged Phase of Immune Suppression through COX-1/mPGES-1-Derived Prostaglandin E2.COX inhibition reduces vasodilator PGE2 but is shown to increase levels of chemoattractant 12-HETE in vivo in human sunburn.Obesity-induced changes in lipid mediators persist after weight loss.Versatility of tandem mass spectrometry for focused analysis of oxylipids.Simultaneous LC-MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF.A comparison of heart rate variability, n-3 PUFA status and lipid mediator profile in age- and BMI-matched middle-aged vegans and omnivores.Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.N-Acyl ethanolamide and eicosanoid involvement in irritant dermatitis
P2860
Q26823893-CD8DDABA-D0EB-472D-A587-F873C17D16A4Q33652547-62448BEE-824C-458D-A455-FEBA5A2E121CQ33790988-6BA7F518-5D28-4862-A26A-06FA24A7C1AFQ34042152-7745ED0E-0C25-4F80-B390-63E489278018Q35070934-933AD553-2327-4B51-8EF6-19ACA8376714Q35992577-C67DBCB4-AE95-4E0D-8684-076D2666E1A9Q37172113-90BDAF00-40D1-4FC7-A5EE-5B33F1E5A092Q37681393-DE62214F-08A4-4CE2-A637-19245D0DCD18Q38111301-F746EB72-34B0-4F2D-AAB9-5C8F2798D2E8Q38636997-1C38DBB5-950D-4BE6-8F42-A3612859F7E7Q38955402-D644E33C-717E-43F6-BA23-124105401C2CQ40758763-5867BC26-1F26-400C-8EF2-4A16E81E7827Q41904365-1B00C451-41B5-447F-9ED0-DC3D270D18A6Q42376227-6A8A3A07-B1C7-4684-8DF4-994804DCE7C5Q42544776-8991FE5D-C55E-4939-8C1A-012240DFB74CQ45961332-A7E253F1-E4B6-43C5-836E-34A93A520EABQ46672709-E61F43BC-855E-4701-BF03-A49C8E0C3E87Q47678157-59BD8BCE-68C8-4EF1-9EE9-95D36B8C4C61Q47746939-BA47709A-525D-42BD-BE40-33A92E89CFF8Q52369219-7474516F-3D5E-4827-B038-4BA589E0B2BAQ58365600-46E3EE35-1526-456A-8240-3DC915AE369B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipidomics of oxidized polyunsaturated fatty acids
@en
Lipidomics of oxidized polyunsaturated fatty acids.
@nl
type
label
Lipidomics of oxidized polyunsaturated fatty acids
@en
Lipidomics of oxidized polyunsaturated fatty acids.
@nl
prefLabel
Lipidomics of oxidized polyunsaturated fatty acids
@en
Lipidomics of oxidized polyunsaturated fatty acids.
@nl
P2860
P1476
Lipidomics of oxidized polyunsaturated fatty acids
@en
P2093
Karen A Massey
P2860
P356
10.1016/J.FREERADBIOMED.2012.08.565
P577
2012-08-19T00:00:00Z